Increased metabolic demands in cancer could be responsible for obesity-related mitochondrial dysfunction since there were no changes in the protein level of PDH and citrate synthase in the CAAT of obese women with malignant tumors. The gene discussed is PDP1; the disease is obesity due to melanocortin 4 receptor deficiency.